OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.18−0.18 (-12.96%)
Close on Nov 16, 2026Market cap $61.66MP/E –Yield –
OKYO Pharma total assets
Total assets on the balance sheet at the end of each period.
OKYO Pharma's total assets was $20.98M at Mar 31, 2026. For fiscal 2026 it was $20.98M, up 470.4% from the year before. The highest annual figure on record is $20.98M in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $20.98M | +470.4% |
| FY2025 | Mar 31, 2025 | $3.68M | +138.6% |
| FY2024 | Mar 31, 2024 | $1.54M | -70.4% |
| FY2023 | Mar 31, 2023 | $5.20M | +21.0% |
| FY2022 | Mar 31, 2022 | $4.30M | -39.4% |
| FY2021 | Mar 31, 2021 | $7.09M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $20.98M | +387.8% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $3.68M | -48.1% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $1.54M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $5.20M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $4.30M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $7.09M | – |
See a number that looks wrong?